Novo in brief

Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.

Novo A/S is the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.

Novo A/S’ objective is to manage the Foundation’s financial assets through investments in the life science area and in a broad portfolio of financial assets.

Read more

Annual Report 2010